how big is the glp-1 market Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Receptor Agonist Market Size,

So over 16 weeks they get cranked up to very high doses, which I think are significantly way, way, way too high and theyre wasting

Both companies agreed to sell their GLP-1 medications at significant discounts through the TrumpRx direct-to-consumer platform

This decline is connected to a lower risk for heart disease and diabetes

Herbs and Spices: Turmeric, ginger, and garlic amplify flavor and provide medicinal benefits

One participant stated: "While on Mounjaro, I couldn't smoke, but after stopping it for about a month, I went back to smoking." (Male, 8 months on GLP-1 therapy) "During the period of use, the need for nicotine noticeably decreased, but after the treatment period ended, the desire to smoke gradually increased." (Male, 6 months on GLP-1 therapy) In contrast, a subset of participants reported no observable perceived impact of GLP-1 on their smoking behavior